Work in HR? Unlock Free Profile
Suggest Edits

Be The First To
Add Photos

Headquarters Menlo Park, CA
Size 50 to 149 Employees
Founded Unknown
Type Company - Public (GERN)
Industry Biotech & Pharmaceuticals
Revenue Less than £1 million (GBP) per year

Geron is working to get important things into our thick heads -- more specifically, it is developing a compound able to penetrate the blood-brain barrier that otherwise keeps potentially valuable drugs out of the brain. The company's research and development is targeting viable therapies for cancer, injury, and degenerative diseases. One of the company's lead products in clinical trials is an hESC therapy (derived from human stem cells) called GRNOPC1 for spinal cord injury. Geron is also focused on anticancer drug candidate GRN163L, which inhibits telomerase, an enzyme... More

Working at Geron

Posted by employees

Employees are “Dissatisfied”   7 ratings


100% Approve of the CEO   1 ratings

Geron Director, President & CEO John A. Scarlett

John A. Scarlett

Director, President & CEO

Challenging and ultimately rewarding

  Current Employee

Pros: Very interesting, potentially revolutionary science Full Review

More Geron Ratings & Reviews ( 7)

Geron Awards and Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Worked for Geron? Contribute to the Community!